Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CVE | XOM |
|---|---|---|
| Price | $31.33 | $161.49 |
| Change today | ▲ 0.80% | ▲ 0.16% |
| Market cap | $57.78B | $664.03B |
| Return, 3 months | +26.9% | +18.7% |
| Return, year to date | +87.4% | +36.9% |
| Return, 1 year | +79.4% | +45.1% |
| P/E (TTM) | 12.3 | 20.8 |
| P/B | 2.4 | 2.6 |
| P/E percentile vs own 5y | 56th | 90th |
| Dividend yield | 1.84% | 2.53% |
| Revenue growth (YoY, latest qtr) | +47.5% | +44.1% |
| Net profit growth (YoY) | +237.3% | +102.4% |
| Gross margin | 28.0% | 20.6% |
| Operating margin | 16.0% | 10.7% |
| Net margin | 11.5% | 9.1% |
| Return on equity | 21.0% | 12.6% |
| Analyst target vs. price | +19.6% | +5.4% |
| Analyst buy share | 90% | 50% |
| RSI (14) | 48 | 51 |
| 30-day volatility | 31.0% | 25.7% |
| Max drawdown, 1 year | -23.0% | -20.1% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.